OSN New York and OSN New York Retina

OSN New York and OSN New York Retina

Source:

Loh J. Arriving soon: Drops for presbyopia and their impact on refractive surgery. Presented at: OSN New York and OSN New York Retina; Oct. 15-17, 2021; New York.

Disclosures: Loh reports having financial disclosures for Aerie Pharmaceuticals, Alcon Pharmaceuticals, Allergan, Bausch + Lomb, Eyepoint, Eyevance, Imprimis, Johnson & Johnson Vision, Kala Pharmaceuticals, NovaBay, Novartis, Ocular Therapeutix, Omeros, Orasis Pharmaceuticals, Sight Sciences, Sun Ophthalmics and Zeiss.
October 17, 2021
1 min read
Save

Presbyopia-correcting drops could be temporary step before future surgery

Source:

Loh J. Arriving soon: Drops for presbyopia and their impact on refractive surgery. Presented at: OSN New York and OSN New York Retina; Oct. 15-17, 2021; New York.

Disclosures: Loh reports having financial disclosures for Aerie Pharmaceuticals, Alcon Pharmaceuticals, Allergan, Bausch + Lomb, Eyepoint, Eyevance, Imprimis, Johnson & Johnson Vision, Kala Pharmaceuticals, NovaBay, Novartis, Ocular Therapeutix, Omeros, Orasis Pharmaceuticals, Sight Sciences, Sun Ophthalmics and Zeiss.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW YORK — Presbyopia-correcting drops may be a good choice for patients who previously underwent corneal refractive surgery and can act as a temporizing measure until further surgery becomes necessary, according to a speaker here.

“There are many solutions. However, none of them have been a slam dunk,” Jennifer Loh, MD, said at OSN New York.

The majority of companies currently working on drops for presbyopia are focused on a method of action targeting pupil modulation, Loh said. The goal for these drops is to increase patients’ range of vision without compromising distance vision and with minimum side effects.

Jennifer Loh

“Obviously, the first goal for drops would be to help patients regain their vision up close,” Loh said. A secondary goal is to keep patients appearing youthful and free of spectacles.

Presbyopia-correcting drops would be especially useful for patients who are not strong candidates for corneal refractive surgery if they have undergone previous procedures or if they are in the early stages of presbyopia, Loh said.

“We want to just have something that could give us the benefit of not needing glasses or contact lenses,” she said. “Drops could be a great bridge to possible surgery in the future.”